Lava Therapeutics NV - Yalelaan 60
Lava Therapeutics - Lavatherapeutics.com
Innovation in engaging gamma-delta T cells to potently and precisely fight cancer
About Lava Therapeutics NV
We are building a pipeline of Gammabody™ drug candidates that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor-specific antigen CD1d, which can be overexpressed in multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), among other tumor types. Enrollment is now open in our open-label, multi-center, Phase 1/2a clinical trial of LAVA-051 for the treatment of relapsed and/or refractory CLL, MM and AML. The trial is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary antitumor activity of LAVA-051. Click here to learn more about the trial
Contact Lava Therapeutics NV
| Address : | Yalelaan 60, 3584 CM Utrecht, Netherlands |
| Postal code : | 3584 |
| Website : | https://lavatherapeutics.com/ |
| Categories : | |
| City : | Utrecht |
Write some of your reviews for the company Lava Therapeutics NV
Your reviews will be very helpful to other customers in finding and evaluating information
Nearby places in the field of Biotechnology company,
Nearby places Lava Therapeutics NV
